Biotime's Dengue Ag&Ab Combo Rapid Test has undergone rigorous evaluation and has met the standards required for Thai Medical Device Import Licensing. This significant achievement underscores Biotime's unwavering commitment to delivering cutting-edge diagnostic solutions to the global healthcare community.

The acquisition of Thai Medical Device Import Licensing marks a pivotal milestone for Biotime. With this regulatory approval, Biotime can now expand the availability of its Dengue Ag&Ab Combo Rapid Test in Thailand, effectively addressing the pressing need for accurate and timely dengue diagnosis in the region.

Dengue, a prevalent mosquito-borne disease, poses a significant health challenge worldwide. Biotime acknowledges the urgency of combatting this disease and is proud to contribute to the collective effort. By providing healthcare professionals with access to our Dengue Ag&Ab Combo Rapid Test, we empower them to make informed decisions for effective dengue management and patient care.

The Dengue Ag&Ab Combo Rapid Test offers a comprehensive solution for the qualitative detection of NS1 antigen and IgG/IgM antibodies to all four serotypes of the Dengue virus. With results available in just minutes, our rapid lateral flow immunoassay enables early detection and prompt treatment, crucial for successful patient outcomes.

Furthermore, Biotime's Dengue Ag&Ab Combo Rapid Test distinguishes between primary and secondary infections, aiding healthcare professionals in tailoring appropriate interventions. This differentiation is vital in optimizing patient management strategies and allocating healthcare resources efficiently.

Biotime remains steadfast in its mission to create a healthier and safer world. Through continued innovation, dedication, and collaboration with the global healthcare community, we strive to make a meaningful impact in the fight against infectious diseases.

Biotime is a leading provider of innovative diagnostic solutions, committed to improving global healthcare outcomes. With a focus on infectious diseases, Biotime develops cutting-edge rapid tests that deliver accurate results in a timely manner. By harnessing the power of technology and scientific advancements, Biotime aims to create a healthier and safer world for all.